Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28,027,744
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
14,576,884
-
Shares change
-
-1,691,822
-
Total reported value, excl. options
-
$11,238,169
-
Value change
-
-$3,082,628
-
Number of buys
-
12
-
Number of sells
-
19
-
Price
-
$0.7710
Institutional Holders of NextCure, Inc. - Common Stock (NXTC) as of Q4 2024
As of 31 Dec 2024 NextCure, Inc. - Common Stock (NXTC) had 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 14,576,884 shares of stock of the company.
Largest 10 holders included Sofinnova Investments, Inc., Affinity Asset Advisors, LLC, CITIGROUP INC, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, BlackRock, Inc., TANG CAPITAL MANAGEMENT LLC, Cable Car Capital, LP, RENAISSANCE TECHNOLOGIES LLC, and ACADIAN ASSET MANAGEMENT LLC.
This table shows 45 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.